CD274 and thyroiditis: PD-1/PD-L1 immunotherapy may cause immune pneumonitis, skin rash, thyroiditis, and other adverse reactions 12-14, whereas immunohistochemistry (IHC) cannot enable the mechanistic prediction and monitoring of the occurrence of these side effects.